Vincent Aurentz
CIK 1657494 · Executive VP and CBO · last filed 2026-02-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$852.7K
Companies
4
Total Filings
28
Lifetime Open-Market Net
-$5.57M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IKT | Director | 510,596 | $1.67 | $852.7K | $0 | 4 | 2026-02-24 |
| Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Director | — | $59.98 | — | $0 | 5 | 2024-12-02 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | Executive VP and CBO | 0 | $99.99 | $0 | -$5.59M | 15 | 2022-03-11 |
| EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Chief Business Officer | 5,000 | — | — | $18.3K | 4 | 2016-05-31 |
Recent Filings · Page 3 of 3
28 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-08 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-22 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-02-14 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-08-15 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-31 | EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-12-21 | EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Buy (P) | +2,200 | $7.5K | EDGAR |
| 2015-12-11 | EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Buy (P) | +2,800 | $10.8K | EDGAR |
| 2015-11-10 | EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–28 of 28
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.